Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease's intricate and varied nature.

Herein, we developed a carrier-free nanocombo comprising a photosensitizer (chlorin e6, Ce6) and an α2-adrenergic receptor agonist (guanfacine, GFC) to enhance photoimmunotherapy via α2-AR activation.

Department of Anatomy and Neurobiology, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea Department of Precision Medicine, Graduate School, Kyung Hee University, Seoul 02447, ...

Photodynamic therapy (PDT) is a promising non-invasive therapeutic approach that utilizes photosensitizers (PSs) to generate highly reactive oxygen species (ROS), including singlet oxygen, for removal ...

Lung cancer, a predominant source of cancer-related mortality, poses considerable obstacles for conventional therapies. Carbon nanotubes, an innovative category of nanomaterials, have surfaced as ...